Medicinal Genomics Launches Cannabis Genome Library

Medicinal Genomics launches Kannapedia 2.0, the world’s most comprehensive cannabis genomic library genomic technology platform, sets new standards for completeness, capability, and popularity.

Medicinal Genomics Corp. (MGC), a pioneer in harnessing genomics to improve agricultural productivity, safety and transparency, today announced the launch of Kannapedia 2.0, (https://www.kannapedia.net), a technology platform that enables crop innovation for the cannabis and hemp industry. 

The platform contains an ever-expanding genetic library that aims to shave years off the traditional crop breeding process to improve product quality and long-term sustainability of the industry.

“Kannapedia unlocks the value of our genomic services. The insights garnered from utilizing our vast array of sequencing and genotyping services in conjunction with Kannapedia will drive crop innovation” said Mike Catalano, MGC’s head of genomic services. 

“Now, Kannapedia makes it easier than ever for customers to discover genetic targets by identifying high-impact variants in genes of interest. It will also serve as a powerful research tool for enabling more discoveries of quantitative traits and expanding the diversity of cannabis cultivars assessed in genetic prediction. It’s the state of the art in cannabis genomics.” 

Kannapedia 2.0 will help interpret genes impacting flowering, Edestin synthesis, disease and pathogen resistance, as well as cannabinoid, terpenoid and CannFlavin synthesis. 

Like its predecessor, Kannapedia 2.0 is publicly available, but now features the genomes of more than 1,400 unique, registered cannabis strains. 

Please contact frank.priscaro@medicinalgenomics for more information

This article has been republished from material provided by Medicinal Genomics. Note: material may have been edited for length and content. For further information, please contact the cited source.